Search

Your search keyword '"Yamao, Kenji"' showing total 19 results
Start Over Author "Yamao, Kenji" Publication Year Range Last 3 years
19 results on '"Yamao, Kenji"'

2. Endoscopic Ultrasound Can Differentiate High-Grade Pancreatic Intraepithelial Neoplasia, Small Pancreatic Ductal Adenocarcinoma, and Benign Stenosis

Author

Sagami, Ryota, primary, Yamao, Kentaro, additional, Minami, Ryuki, additional, Nakahodo, Jun, additional, Akiyama, Hidetoshi, additional, Nishikiori, Hidefumi, additional, Mizukami, Kazuhiro, additional, Yamao, Kenji, additional, Bhatia, Vikram, additional, Amano, Yuji, additional, and Murakami, Kazunari, additional

Published
2023
Full Text
View/download PDF

3. Supplementary Table 3 from Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer

Author

Ichimura, Norihisa, primary, Shinjo, Keiko, primary, An, Byonggu, primary, Shimizu, Yasuhiro, primary, Yamao, Kenji, primary, Ohka, Fumiharu, primary, Katsushima, Keisuke, primary, Hatanaka, Akira, primary, Tojo, Masayuki, primary, Yamamoto, Eiichiro, primary, Suzuki, Hiromu, primary, Ueda, Minoru, primary, and Kondo, Yutaka, primary

Published
2023
Full Text
View/download PDF

4. Supplementary Fig. 2 from Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer

Author

Ichimura, Norihisa, primary, Shinjo, Keiko, primary, An, Byonggu, primary, Shimizu, Yasuhiro, primary, Yamao, Kenji, primary, Ohka, Fumiharu, primary, Katsushima, Keisuke, primary, Hatanaka, Akira, primary, Tojo, Masayuki, primary, Yamamoto, Eiichiro, primary, Suzuki, Hiromu, primary, Ueda, Minoru, primary, and Kondo, Yutaka, primary

Published
2023
Full Text
View/download PDF

5. Supplementary Fig. 1 from Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer

Author

Ichimura, Norihisa, primary, Shinjo, Keiko, primary, An, Byonggu, primary, Shimizu, Yasuhiro, primary, Yamao, Kenji, primary, Ohka, Fumiharu, primary, Katsushima, Keisuke, primary, Hatanaka, Akira, primary, Tojo, Masayuki, primary, Yamamoto, Eiichiro, primary, Suzuki, Hiromu, primary, Ueda, Minoru, primary, and Kondo, Yutaka, primary

Published
2023
Full Text
View/download PDF

6. Supplementary Table 4 from Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer

Author

Ichimura, Norihisa, primary, Shinjo, Keiko, primary, An, Byonggu, primary, Shimizu, Yasuhiro, primary, Yamao, Kenji, primary, Ohka, Fumiharu, primary, Katsushima, Keisuke, primary, Hatanaka, Akira, primary, Tojo, Masayuki, primary, Yamamoto, Eiichiro, primary, Suzuki, Hiromu, primary, Ueda, Minoru, primary, and Kondo, Yutaka, primary

Published
2023
Full Text
View/download PDF

7. Supplementary Figure legends from Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer

Author

Ichimura, Norihisa, primary, Shinjo, Keiko, primary, An, Byonggu, primary, Shimizu, Yasuhiro, primary, Yamao, Kenji, primary, Ohka, Fumiharu, primary, Katsushima, Keisuke, primary, Hatanaka, Akira, primary, Tojo, Masayuki, primary, Yamamoto, Eiichiro, primary, Suzuki, Hiromu, primary, Ueda, Minoru, primary, and Kondo, Yutaka, primary

Published
2023
Full Text
View/download PDF

8. Supplementary Table 1 from Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer

Author

Ichimura, Norihisa, primary, Shinjo, Keiko, primary, An, Byonggu, primary, Shimizu, Yasuhiro, primary, Yamao, Kenji, primary, Ohka, Fumiharu, primary, Katsushima, Keisuke, primary, Hatanaka, Akira, primary, Tojo, Masayuki, primary, Yamamoto, Eiichiro, primary, Suzuki, Hiromu, primary, Ueda, Minoru, primary, and Kondo, Yutaka, primary

Published
2023
Full Text
View/download PDF

9. Data from Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer

Author

Ichimura, Norihisa, primary, Shinjo, Keiko, primary, An, Byonggu, primary, Shimizu, Yasuhiro, primary, Yamao, Kenji, primary, Ohka, Fumiharu, primary, Katsushima, Keisuke, primary, Hatanaka, Akira, primary, Tojo, Masayuki, primary, Yamamoto, Eiichiro, primary, Suzuki, Hiromu, primary, Ueda, Minoru, primary, and Kondo, Yutaka, primary

Published
2023
Full Text
View/download PDF

10. Supplementary Table 2 from Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer

Author

Ichimura, Norihisa, primary, Shinjo, Keiko, primary, An, Byonggu, primary, Shimizu, Yasuhiro, primary, Yamao, Kenji, primary, Ohka, Fumiharu, primary, Katsushima, Keisuke, primary, Hatanaka, Akira, primary, Tojo, Masayuki, primary, Yamamoto, Eiichiro, primary, Suzuki, Hiromu, primary, Ueda, Minoru, primary, and Kondo, Yutaka, primary

Published
2023
Full Text
View/download PDF

11. Supplementary Figure 2 from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Author

Sawada, Yu, primary, Yoshikawa, Toshiaki, primary, Nobuoka, Daisuke, primary, Shirakawa, Hirofumi, primary, Kuronuma, Toshimitsu, primary, Motomura, Yutaka, primary, Mizuno, Shoichi, primary, Ishii, Hiroshi, primary, Nakachi, Kohei, primary, Konishi, Masaru, primary, Nakagohri, Toshio, primary, Takahashi, Shinichiro, primary, Gotohda, Naoto, primary, Takayama, Tadatoshi, primary, Yamao, Kenji, primary, Uesaka, Katsuhiko, primary, Furuse, Junji, primary, Kinoshita, Taira, primary, and Nakatsura, Tetsuya, primary

Published
2023
Full Text
View/download PDF

12. Supplementary Figure 1 from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Author

Sawada, Yu, primary, Yoshikawa, Toshiaki, primary, Nobuoka, Daisuke, primary, Shirakawa, Hirofumi, primary, Kuronuma, Toshimitsu, primary, Motomura, Yutaka, primary, Mizuno, Shoichi, primary, Ishii, Hiroshi, primary, Nakachi, Kohei, primary, Konishi, Masaru, primary, Nakagohri, Toshio, primary, Takahashi, Shinichiro, primary, Gotohda, Naoto, primary, Takayama, Tadatoshi, primary, Yamao, Kenji, primary, Uesaka, Katsuhiko, primary, Furuse, Junji, primary, Kinoshita, Taira, primary, and Nakatsura, Tetsuya, primary

Published
2023
Full Text
View/download PDF

13. Supplementary Figure Legend from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Author

Sawada, Yu, primary, Yoshikawa, Toshiaki, primary, Nobuoka, Daisuke, primary, Shirakawa, Hirofumi, primary, Kuronuma, Toshimitsu, primary, Motomura, Yutaka, primary, Mizuno, Shoichi, primary, Ishii, Hiroshi, primary, Nakachi, Kohei, primary, Konishi, Masaru, primary, Nakagohri, Toshio, primary, Takahashi, Shinichiro, primary, Gotohda, Naoto, primary, Takayama, Tadatoshi, primary, Yamao, Kenji, primary, Uesaka, Katsuhiko, primary, Furuse, Junji, primary, Kinoshita, Taira, primary, and Nakatsura, Tetsuya, primary

Published
2023
Full Text
View/download PDF

14. Supplementary Table 2 from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Author

Sawada, Yu, primary, Yoshikawa, Toshiaki, primary, Nobuoka, Daisuke, primary, Shirakawa, Hirofumi, primary, Kuronuma, Toshimitsu, primary, Motomura, Yutaka, primary, Mizuno, Shoichi, primary, Ishii, Hiroshi, primary, Nakachi, Kohei, primary, Konishi, Masaru, primary, Nakagohri, Toshio, primary, Takahashi, Shinichiro, primary, Gotohda, Naoto, primary, Takayama, Tadatoshi, primary, Yamao, Kenji, primary, Uesaka, Katsuhiko, primary, Furuse, Junji, primary, Kinoshita, Taira, primary, and Nakatsura, Tetsuya, primary

Published
2023
Full Text
View/download PDF

15. Supplementary Table 1 from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Author

Sawada, Yu, primary, Yoshikawa, Toshiaki, primary, Nobuoka, Daisuke, primary, Shirakawa, Hirofumi, primary, Kuronuma, Toshimitsu, primary, Motomura, Yutaka, primary, Mizuno, Shoichi, primary, Ishii, Hiroshi, primary, Nakachi, Kohei, primary, Konishi, Masaru, primary, Nakagohri, Toshio, primary, Takahashi, Shinichiro, primary, Gotohda, Naoto, primary, Takayama, Tadatoshi, primary, Yamao, Kenji, primary, Uesaka, Katsuhiko, primary, Furuse, Junji, primary, Kinoshita, Taira, primary, and Nakatsura, Tetsuya, primary

Published
2023
Full Text
View/download PDF

16. ENDOSCOPIC ULTRASOUND CAN DIFFERENTIATE HIGH-GRADE PANCREATIC INTRAEPITHELIAL NEOPLASIA, SMALL PANCREATIC DUCTAL ADENOCARCINOMA, AND BENIGN STENOSIS. A MULTICENTER COMPARATIVE STUDY．

Author

Sagami, Ryota, primary, Yamao, Kentaro, additional, Minami, Ryuki, additional, Nakahodo, Jun, additional, Akiyama, Hidetoshi, additional, Nishikiori, Hidefumi, additional, Mizukami, Kazuhiro, additional, Yamao, Kenji, additional, Amano, Yuji, additional, and Murakami, Kazunari, additional

Published
2022
Full Text
View/download PDF

18. Endoscopic Ultrasound Can Differentiate High-Grade Pancreatic Intraepithelial Neoplasia, Small Pancreatic Ductal Adenocarcinoma, and Benign Stenosis.

Author

Sagami R, Yamao K, Minami R, Nakahodo J, Akiyama H, Nishikiori H, Mizukami K, Yamao K, Bhatia V, Amano Y, and Murakami K

Subjects
Humans, Constriction, Pathologic diagnostic imaging, Constriction, Pathologic pathology, Endosonography, Pancreatic Ducts diagnostic imaging, Pancreatic Ducts pathology, Retrospective Studies, Carcinoma in Situ diagnostic imaging, Carcinoma in Situ pathology, Carcinoma, Pancreatic Ductal pathology, Pancreatic Neoplasms pathology
Abstract

Background/aims: High-grade pancreatic intraepithelial neoplasia and invasive pancreatic ductal adenocarcinoma ≤10 mm are targets for early detection of pancreatic cancer. However, their imaging characteristics are unknown. We aimed to identify endoscopic ultrasound findings for the detection of these lesions., Methods: Patients diagnosed with high-grade pancreatic intraepithelial neoplasia (n=29), pancreatic ductal adenocarcinoma ≤10 mm (n=11) (who underwent surgical resection), or benign main pancreatic duct stenosis (n=20) between January 2014 and January 2021 were retrospectively included. Six features differentiating these lesions were examined by endoscopic ultrasonography: main pancreatic duct stenosis, upstream main pancreatic duct dilation, hypoechoic areas surrounding the main pancreatic duct irregularities (mottled areas without demarcation or round areas with demarcation), branch duct dilation, prominent lobular segmentation, and atrophy. Interobserver agreement was assessed by two independent observers., Results: Hypoechoic areas surrounding the main pancreatic duct irregularities were observed more frequently in high-grade pancreatic intraepithelial neoplasia (82.8%) and pancreatic ductal adenocarcinoma ≤10 mm (90.9%) than in benign stenosis (15.0%) (p<0.001). High-grade pancreatic intraepithelial neoplasia exhibited mottled hypoechoic areas more frequently (79.3% vs 18.9%, p<0.001), and round hypoechoic areas less frequently (3.4% vs 72.7%, p<0.001), than pancreatic ductal adenocarcinoma ≤10 mm. The sensitivity and specificity of hypoechoic areas for differentiating high-grade pancreatic intraepithelial neoplasia, pancreatic ductal adenocarcinoma ≤10 mm, and benign stenosis were both 85.0%, with moderate interobserver agreement., Conclusions: The hypoechoic areas surrounding main pancreatic duct irregularities on endoscopic ultrasound may differentiate between high-grade pancreatic intraepithelial neoplasia, pancreatic ductal adenocarcinoma ≤10 mm, and benign stenosis (Trial Registration: UMIN Clinical Trials Registry (UMIN000044789).

Published
2024
Full Text
View/download PDF

19. Treatment Outcome of Nab-paclitaxel Plus Gemcitabine for Leptomeningeal Carcinomatosis from Pancreatic Ductal Adenocarcinoma: An Autopsy Case Report.

Author

Iwatsuka K, Kikuta D, Shibuya H, Ogawa M, Gotoda T, Moriyama M, Nakagawara H, Hemmi A, and Yamao K

Subjects
Albumins therapeutic use, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Autopsy, Deoxycytidine analogs & derivatives, Female, Humans, Middle Aged, Paclitaxel therapeutic use, Treatment Outcome, Gemcitabine, Adenocarcinoma drug therapy, Meningeal Carcinomatosis drug therapy, Pancreatic Neoplasms drug therapy
Abstract

A 57-year-old woman with a sudden-onset seizure was hospitalized. Brain magnetic resonance imaging findings led to a suspicion of leptomeningeal carcinomatosis (LMC) without a brain parenchymal tumor, and abdominal computed tomography showed a tumor in the pancreatic tail. Endoscopic ultrasonography-guided fine needle aspiration of the pancreatic mass revealed adenocarcinoma. Therefore, LMC from pancreatic ductal adenocarcinoma was strongly suspected. She received three courses of nab-paclitaxel plus gemcitabine and whole-brain radiation. Shortly thereafter, she developed a severe consciousness impediment and died. A pathological autopsy showed adenocarcinoma in a wide area of the leptomeninges.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results